← Study Library
Cohort · 2017 · n=143
Preclinicalcounts toward this tierIncreased Expression of Thymosin β4 Is Independently Correlated with Hypoxia Inducible Factor-1α (HIF-1α) and Worse Clinical Outcome in Human Colorectal Cancer
Lee SY, Park MJ, Lee HK, Son HJ, Kim CN, Kim JH, Kang DW · Journal of Pathology and Translational Medicine
Preclinicalcounts toward this tier
High tumour Tβ4 correlated with lymphovascular invasion, invasion depth, nodal and distant metastasis and TNM stage, and independently predicted worse recurrence-free (p=0.001) and overall survival (p=0.005) on multivariate analysis — relative risk 2.54 (95% CI 1.48 to 4.36) for recurrence and 2.46 (1.32 to 4.59) for death over a mean 53 months of follow-up.
- Population
- 143 patients with colorectal cancer, tumour immunohistochemistry
- Intervention
- None — observational
- Comparator
- Low versus high tumour Tβ4 expression
- Limitations
- Prognostic association in existing tumours; says nothing about whether Tβ4 exposure initiates cancer, and expression inside a tumour is not the same variable as an injected dose. Expression scored by two pathologists blinded to outcome and cut at the series median; no conflict reported and no funding statement.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental
Evidence for that entry
Preclinical